Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis

Pharmacol Res. 2021 Oct:172:105849. doi: 10.1016/j.phrs.2021.105849. Epub 2021 Aug 24.

Abstract

Nonalcoholic steatohepatitis (NASH) is a common chronic liver disease in clinical practice. It has been considered that NASH is one of the main causes of chronic liver disease, cirrhosis and carcinoma. The mechanism of the NASH progression is complex, including lipid metabolism dysfunction, insulin resistance, oxidative stress, inflammation, apoptosis, fibrosis and gut microbiota dysbiosis. Except for lifestyle modification and bariatric surgery, there has been no pharmacological therapy that is being officially approved in NASH treatment. Traditional Chinese medicine (TCM), as a conventional and effective therapeutic strategy, has been proved to be beneficial in treating NASH in numbers of studies. In the light of this, TCM may provide a potential therapy for treating NASH. In this review, we summarized the associated mechanisms of action TCM treating NASH in preclinical studies and systematically analysis the effectiveness of TCM treating NASH in current clinical trials.

Keywords: Fibrosis; Gut microbiota; Inflammation; Lipid metabolism; Nonalcoholic steatohepatitis; Review; Traditional Chinese medicine.

Publication types

  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Animals
  • Humans
  • Medicine, Chinese Traditional*
  • Non-alcoholic Fatty Liver Disease / drug therapy*
  • Randomized Controlled Trials as Topic